Company: ENTXW
Filing Date: 2025-06-05
Form Type: DEF 14A
Source: 0001178913-25-002111
Chunk: 35

Company: Entera Bio Ltd.
Filing Date: 2025-06-05
Form: DEF 14A
Chunk 35
---
1.56 | % |
| Hillel Galitzer(8)                                                       |     |                          |   587,656 |     |         |  1.28 | % |
| Sean Ellis(9)                                                            |     |                          |   523,403 |     |         |  1.14 | % |
| Yonatan Malca(10)                                                        |     |                          |   435,935 |     |         |     * |   |
| Gerald M. Ostrov(11)                                                     |     |                          |   435,612 |     |         |     * |   |
| Dana Yaacov-Garbeli(12)                                                  |     |                          |   408,500 |     |         |     * |   |
| Gregory Burshtein(13)                                                    |     |                          |   281,276 |     |         |     * |   |
| Haya Taitel(14)                                                          |     |                          |   209,663 |     |         |     * |   |
| Leslie Gautaum                                                           |     |                          |         - |     |         |     - |   |
| All Directors and Executive Officers as a Group (10 persons)(15)         |     |                          | 5,160,720 |     |         | 10.38 | % |

* Less than 1% Entera Bio Ltd. | 2025 Annual Meeting Proxy Statement 19

| (1) | Pursuant to the Schedule 13G/A filed with the SEC on November 14, 2024 regarding Gasaka Holdings LLC’s holdings. This consists of: (i) 5,534,275 Ordinary Shares, (ii) 347,604 Ordinary Shares underlying Pre-Funded Warrants (iii) 1,197,604 Ordinary Shares underlying warrants to acquire Ordinary Shares. Gasaka Holdings LLC’s address is at 201 S. Biscayne Blvd suite 800, Miami, FL 33131. |

| (2) | D.N.A Biomedical Solutions Ltd.’s holdings consisted of 3,762,960 Ordinary Shares. D.N.A’s address is at Shimon Hatarsi 43 St., Tel Aviv, Israel. |

| (3) | Pursuant to the Schedule 13G filed with the SEC on January 6, 2025 regarding Point72 Asset Management, L.P.’s holdings. Beneficial ownership includes 2,701,560 Ordinary